My HPRA: Register

KEVZARA

200 Milligram Solution for Injection

Sanofi-Aventis GroupeEU/1/17/1196/003-008

Main Information

Trade NameKEVZARA
Active SubstancesSARILUMAB
Strength200 Milligram
Dosage FormSolution for Injection
Licence HolderSanofi-Aventis Groupe
Licence NumberEU/1/17/1196/003-008

Group Information

ATC CodeL04AC14 Sarilumab

Status

Authorised/WithdrawnAuthorised
Licence Issued23/06/2017
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print